Safety of long-term PPI therapy

Area of Science:

• Gastroenterology
• Pharmacology
• Internal Medicine

Background:

• Proton pump inhibitors (PPIs) are a primary treatment for acid-related gastrointestinal disorders.
• Long-term PPI use is increasing, sometimes without clear medical necessity.
• Extensive research has explored potential adverse effects associated with PPI therapy.

Purpose of the Study:

• To critically review observational studies on PPI associations.
• To evaluate existing evidence on PPI risks and benefits.
• To translate findings into clinical implications for patient care.

Main Methods:

• Comprehensive literature review of observational studies.
• Critical appraisal of published evidence on PPIs.
• Synthesis of data to assess clinical consequences.

Main Results:

• For most patients with appropriate indications, PPI benefits appear to exceed potential risks.
• Specific patient groups, including the elderly, malnourished, and those with comorbidities, warrant closer monitoring.
• Potential risks in vulnerable populations include enteric infections, fractures, and nutritional deficiencies.

Conclusions:

• PPI treatment benefits generally outweigh risks when indications are appropriate.
• Vulnerable patient populations require careful assessment of PPI necessity.
• Clinical vigilance for adverse events is crucial in elderly, malnourished, and comorbid individuals on long-term PPI therapy.